GARDEN BIOPHARMA: Subsidiary obtains drug registration certificate

GARDEN BIOPHARMA announced that its wholly-owned subsidiary, Zhejiang Garden Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for "Alpha-Lipoic Acid Tablets" and "Bisoprolol Amlodipine Tablets." Alpha-Lipoic Acid Tablets are mainly used for the treatment of diabetic peripheral neuropathy, while Bisoprolol Amlodipine Tablets are primarily used for the treatment of hypertension. The acquisition of the drug registration certificates will further enrich the company's product line, promote the upgrade of product capabilities, and have a positive impact on the company's development